MedPath

Assessment of the Aromatherapy to Alleviate Peri Operative Anxiety in Ambulatory Elective Upper Limb Surgery Under Loco-regional Anesthesia

Not Applicable
Recruiting
Conditions
Anxiety
Interventions
Other: without aromatherapy
Other: Olfactory aromatherapy
Registration Number
NCT03583801
Lead Sponsor
University Hospital, Lille
Brief Summary

AROMA study is a randomised controlled parallel-group single-site study. Patients randomized in the experimental group benefit from the aromatherapy at their arrival in the operating theatre in the recovery room. 2 drops of essential oils are applied on a compress placed next to the head of the patient. This compress is kept until the patient is leaving the operating theatre. Patients randomized in the control group don't benefit from the aromatherapy. The anxiety evolution is measured in both groups with the Amsterdam Preoperative Anxiety and Information Scale (APAIS). The hypothesis is that aromatherapy alleviate peri operative anxiety during an ambulatory elective upper limb surgery under loco-regional anesthesia.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
294
Inclusion Criteria
  • Patient admitted in Hospital Centre for an ambulatory elective upper limb " fast track " surgery
  • Patient with loco-regional anesthesia
  • Patient categorized 3 or less according to the American Society of Anesthesiologists (ASA) score
  • The patient must have given his written consent to participate in the study
  • Patient - insured under the French social security system
  • Patient prepared to comply with all the terms of the study and its length
Exclusion Criteria
  • Epileptic patients
  • Asthmatic patients
  • Patients with cognitive disorders ( Mini Mental Status below 15)
  • Psychiatric disorders : current depression or bipolar disease or anxiety disorders or psychotic disorders according to DSM-V classification
  • American Society of Anesthesiologists score strictly superior to 3
  • Preoperative chronic pain : neuropathic pain, fibromyalgia, polyarthritis
  • Pregnant or breastfeeding woman
  • Patient unable to receive an informed consent and to comply with all the terms of the study
  • Patient without any social insurance
  • Refusal to sign the consent
  • Patient under legal protection
  • Patient in emergency (unstable clinical state)
  • Patient unable to read or write french
  • Patient enrolled in an other clinical trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
without aromatherapywithout aromatherapy-
aromatherapy groupOlfactory aromatherapyThe patient has to choose an essential oil among the 3 proposed : * sweet orange (Citrus sinensis L. Persoon) * fine lavender (Lavandula angustifolia P. Miller) * little seed from the mandarin tree (Citrus reticulata blanco)
Primary Outcome Measures
NameTimeMethod
Amsterdam Preoperative Anxiety and Information Scale (APAIS) score variationBetween time T0 (arrival in the operating room in the recovery room) and time T1 (10 minutes after T0, before loco-regional anesthesia), an average 10 minutes
Secondary Outcome Measures
NameTimeMethod
Anxiety Visual Analogic Scale change after the arrival in the operating roomat baseline and an average at 10 minutes,at 35 minutes, at 70 minutes and at 3 hours after arriving in operating room
Satisfaction Visual analogic Scale change after the arrival in the operating theater.at baseline and an average ,at 35 minutes, at 70 minutes and at 3 hours after arriving in operating room
Percentage of patients needing a perioperative drug-induced sedation.at baseline and an average ,at 35 minutes, at 70 minutes and at 3 hours after arriving in operating room
Comfort Visual analogic Scale variation change after the arrival in the operating theater.at baseline and an average at 35 minutes, at 70 minutes and at 3 hours after arriving in operating room

Trial Locations

Locations (1)

Centre hospitalier

🇫🇷

Valenciennes, France

© Copyright 2025. All Rights Reserved by MedPath